Tonix Pharmaceuticals (O:TNXP)
Additional data support mechanism of action
Data from the Phase IIb BESTFIT trial reported at the American College of Rheumatology (ACR) conference support the idea that improvements in sleep quality are correlated with improvements in pain. As Tonmya (TNX- 102 SL) benefits sleep quality, these data are reassuring and we continue to be confident in the success of the Phase III AFFIRM trial. Data from the AFFIRM trial are expected in Q316.
ACR data suggest correlation between sleep and pain
Data from the BESTFIT trial in fibromyalgia presented at ACR on 10 November demonstrated that improvements in sleep quality were associated with higher responder rates in pain and fibromyalgia. Of the patients who were in the top sleep score improvement tertile, 78% of those in the Tonmya arm were pain responders, compared to just 4% in the bottom sleep score improvement tertile.
To Read the Entire Report Please Click on the pdf File Below